DC Field | Value | Language |
---|---|---|
dc.contributor.author | N H Nam | - |
dc.contributor.author | Y Kim | - |
dc.contributor.author | Y J You | - |
dc.contributor.author | Dong Ho Hong | - |
dc.contributor.author | Hwan Mook Kim | - |
dc.contributor.author | B Z Ahn | - |
dc.date.accessioned | 2017-04-19T08:59:49Z | - |
dc.date.available | 2017-04-19T08:59:49Z | - |
dc.date.issued | 2003 | - |
dc.identifier.issn | 0223-5234 | - |
dc.identifier.uri | 10.1016/S0223-5234(02)01443-5 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/6108 | - |
dc.description.abstract | A series of 2′,5′-dihydroxychalcones were synthesized and evaluated for cytotoxicity against tumor cell lines and human umbilical venous endothelial cells (HUVEC). It was found that chalcones with electron-withdrawing substituents on the B ring exhibited potent cytotoxicity against a variety of tumor cell lines while compounds with electron-releasing groups were less potent in general. Those compounds with B ring replaced by extended or heteroaromatic rings exhibited significant bioactivity. Several compounds were shown to have marked cytotoxic selectivity towards HUVECs. Especially, among the synthesized compounds, 2-chloro-2′,5′-dihydroxychalcone (2-3) showed the highest selectivity index up to 66 in comparison to HCT116 cells. This compound also exhibited strong inhibitory effects on the HUVEC tube formation in an in vitro model. When administered into BDF1 mice bearing Lewis lung carcinoma cells at 50 mg kg-1 day-1, 2-3 was found to inhibit the growth of tumor mass by 60.5% ? | - |
dc.publisher | Elsevier | - |
dc.title | Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity | - |
dc.title.alternative | Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity | - |
dc.type | Article | - |
dc.citation.title | European Journal of Medicinal Chemistry | - |
dc.citation.number | 2 | - |
dc.citation.endPage | 187 | - |
dc.citation.startPage | 179 | - |
dc.citation.volume | 38 | - |
dc.contributor.affiliatedAuthor | Dong Ho Hong | - |
dc.contributor.affiliatedAuthor | Hwan Mook Kim | - |
dc.contributor.alternativeName | 하이남 | - |
dc.contributor.alternativeName | 김용 | - |
dc.contributor.alternativeName | 유영재 | - |
dc.contributor.alternativeName | 홍동호 | - |
dc.contributor.alternativeName | 김환묵 | - |
dc.contributor.alternativeName | 안병준 | - |
dc.identifier.bibliographicCitation | European Journal of Medicinal Chemistry, vol. 38, no. 2, pp. 179-187 | - |
dc.identifier.doi | 10.1016/S0223-5234(02)01443-5 | - |
dc.subject.keyword | 2′,5′-Dihydroxychalcone | - |
dc.subject.keyword | Antiangiogenic activity | - |
dc.subject.keyword | Antitumor activity | - |
dc.subject.keyword | Cytotoxicity | - |
dc.subject.local | 2′,5′-Dihydroxychalcone | - |
dc.subject.local | Antiangiogenic activity | - |
dc.subject.local | anti-angiogenic activity | - |
dc.subject.local | Anti-angiogenic activity | - |
dc.subject.local | Antitumor activity | - |
dc.subject.local | anti-tumor activity | - |
dc.subject.local | antitumor activity | - |
dc.subject.local | Cytotoxicity | - |
dc.subject.local | cytotoxicity | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.